Selective Laser Trabeculoplasty After Failed Phacoemulsification With Eximer Laser Trabeculectomy

Cataract Clinical Trial

— SLT  

Official title:

Effectiveness of Selective Laser Trabeculoplasty (SLT) After Failed Phacoemulsification Cataract Extraction Combined With Eximer Laser Trabeculectomy (Phaco-ELT) in Open Angle Glaucoma and Ocular Hypertension

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02434250
• Other study ID #: SLT after Phaco-ELT
• Status: Completed
• Phase: N/A
• First received: January 29, 2015
• Last updated: June 19, 2017
• Start date: May 2015
• Est. completion date: November 2016

Study information

• Verified date: June 2017
• Source: University of Zurich
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The aim of this study is to evaluate the efficacy of selective laser trabeculoplasty after a prior failed phacoemulsification and Eximer Laser Trabeculectomy.

Description:

This study evaluates the efficacy of selective laser trabeculoplasty after a failed combined procedure of phacoemulsification cataract extraction with intraocular lens implantation plus Eximer Laser Trabeculectomy in open angle glaucoma or ocular hypertension. The success of SLT will be determined by the intraocular pressure and number of hypotensive drugs.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 203
• Est. completion date: November 2016
• Est. primary completion date: October 2016
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• diagnosis of open angle glaucoma or ocular hypertension

• and diagnosis of cataract

Exclusion Criteria:

• diagnosis of angle closure glaucoma

• any optic neuropathy other than glaucoma

Related Conditions & MeSH terms

• Cataract
• Glaucoma
• Glaucoma, Open-Angle
• Hypertension
• Ocular Hypertension
• Open Angle Glaucoma

Intervention

Procedure:
• Selective Laser Trabeculoplasty
Selective Laser Trabeculoplasty is a laser treatment procedure to enhance trabecular aequous humor outflow and thus decrease intraocular pressure.

Locations

Country	Name	City	State
Switzerland	Department of Ophthalmology	Zurich	ZH

Sponsors (1)

Lead Sponsor	Collaborator
University of Zurich

Country where clinical trial is conducted

Switzerland, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Efficacy intraocular pressure	Efficacy as measured by decrease in intraocular pressure from baseline	t0 and t=12 month
Primary	Efficacy medication	as measured by decrease in number of used hypotensive medications	t0 and t=12 month
Secondary	Efficacy visual acuity	Efficacy as increase in best corrected visual acuity	t0 and t=12 month

External Links

•   Study Location